Although prior studies have suggested that the small bowel subsite (duodenum, jejunum, or ileum) may influence the molecular features [3,6,7,8,34,35], we found no significant association between the tumor location and genomic alterations, except for the TP53 mutations, which were more common in jejunal tumors. Here, TP53 is linked to neoplasm.